Αρχειοθήκη ιστολογίου

Πέμπτη 8 Ιουνίου 2017

Alectinib and dacomitinib show potential in separate trials for lung cancer

Data from two separate Phase III clinical trials of lung cancer drugs that target different gene faults in the disease, alectinib (Alecensa) and dacomitinib, indicated promise when compared to existing medication. (Source: Drug Development Technology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sZ2XDV
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader